Phillip Campbell Selected Research

Phillip Campbell Research Topics

2	Systemic Scleroderma (Systemic Sclerosis) 01/2021 - 06/2014
2	Fibrosis (Cirrhosis) 01/2019 - 06/2014
1	Psychotic Disorders (Schizoaffective Disorder) 03/2024
1	Pain (Aches) 01/2022
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 11/2020
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2020
1	Pathologic Complete Response 05/2017
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 05/2017
1	Acute Promyelocytic Leukemia 05/2017

1	Polytetrafluoroethylene (Teflon)FDA Link 03/2024
1	CytokinesIBA 01/2022
1	carfentanil (carfentanyl)IBA 01/2022
1	Interleukin-18 (Interleukin 18)IBA 01/2022
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2022
1	Analgesics (Analgesic Drugs)IBA 01/2022
1	Opioid Analgesics (Opioids)IBA 01/2022
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2021
1	tazemetostatIBA 11/2020
1	idelalisibIBA 01/2020
1	acalabrutinibIBA 01/2020
1	Agammaglobulinaemia Tyrosine KinaseIBA 01/2020
1	Bendamustine Hydrochloride FDA Link 01/2020
1	Rituximab (Mabthera)FDA Link 01/2020
1	3-deazaneplanocinIBA 01/2019
1	Etoposide (VP 16)FDA LinkGeneric 05/2017
1	Cytarabine (Cytosar-U)FDA LinkGeneric 05/2017
1	Core Binding Factors (Core-Binding Factor)IBA 05/2017
1	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 05/2017
1	AnthracyclinesIBA 05/2017
1	Daunorubicin (Cerubidine)FDA LinkGeneric 05/2017
1	Transcription Factors (Transcription Factor)IBA 06/2014
1	myocardinIBA 06/2014
1	Serum Response FactorIBA 06/2014

3	Therapeutics 11/2020 - 06/2014
1	Analgesia 01/2022